Merck KGaA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0006599905
EUR
105.05
-42.55 (-28.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
5,249.00
5,318.00
5,255.00
5,280.00
5,418.00
5,266.00
5,352.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,249.00
5,318.00
5,255.00
5,280.00
5,418.00
5,266.00
5,352.00
Raw Material Cost
2,288.00
2,105.00
2,228.00
2,135.00
2,319.00
2,122.00
2,119.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
121.00
126.00
79.00
78.00
76.00
89.00
72.00
Selling and Distribution Expenses
1,516.00
1,335.00
1,411.00
1,417.00
1,554.00
1,345.00
1,427.00
Other Expenses
54.30
53.40
46.00
47.30
45.10
43.50
57.50
Total Expenditure (Excl Depreciation)
4,468.00
4,100.00
4,178.00
4,103.00
4,400.00
3,991.00
4,193.00
Operating Profit (PBDIT) excl Other Income
781
1218
1077
1177
1018
1275
1159
Other Income
-188.00
146.00
-76.00
-91.00
-84.00
-76.00
-24.00
Operating Profit (PBDIT)
1,503.00
1,822.00
1,458.00
1,559.00
1,485.00
1,648.00
1,815.00
Interest
121.00
126.00
79.00
78.00
76.00
89.00
72.00
Exceptional Items
-71.00
-116.00
-93.00
-51.00
-48.00
-67.00
-277.00
Gross Profit (PBDT)
2,961.00
3,213.00
3,027.00
3,145.00
3,099.00
3,144.00
3,233.00
Depreciation
910.00
458.00
457.00
473.00
551.00
449.00
680.00
Profit Before Tax
401.00
1,122.00
829.00
956.00
809.00
1,043.00
785.00
Tax
77.00
224.00
174.00
218.00
140.00
231.00
180.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
319.00
902.00
652.00
735.00
666.00
809.00
607.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
319.00
902.00
652.00
735.00
666.00
809.00
607.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.00
-4.00
3.00
3.00
3.00
3.00
-2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
324.00
898.00
655.00
738.00
669.00
812.00
605.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
28,592.00
28,936.00
28,258.00
29,823.00
29,914.00
28,323.00
28,549.00
Earnings per share (EPS)
0.73
2.07
1.5
1.69
1.53
1.86
1.4
Diluted Earnings per share
0.73
2.07
1.5
1.69
1.53
1.86
1.4
Operating Profit Margin (Excl OI)
14.88%
22.9%
20.49%
22.29%
18.79%
24.21%
21.66%
Gross Profit Margin
24.98%
29.71%
24.47%
27.06%
25.1%
28.33%
27.37%
PAT Margin
6.08%
16.96%
12.41%
13.92%
12.29%
15.36%
11.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -1.30% vs 1.20% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -63.92% vs 37.10% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 0.89% vs 9.26% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -3.97% vs 59.49% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Merck KGaA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
5,249.00
11,438.00
-6,189.00
-54.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,249.00
11,438.00
-6,189.00
-54.11%
Raw Material Cost
2,288.00
4,501.00
-2,213.00
-49.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
3,100.00
-3,100.00
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
121.00
675.00
-554.00
-82.07%
Selling and Distribution Expenses
1,516.00
3,830.00
-2,314.00
-60.42%
Other Expenses
54.30
-237.00
291.30
122.91%
Total Expenditure (Excl Depreciation)
4,468.00
9,736.00
-5,268.00
-54.11%
Operating Profit (PBDIT) excl Other Income
781.00
1,702.00
-921.00
-54.11%
Other Income
-188.00
-693.00
505.00
72.87%
Operating Profit (PBDIT)
1,503.00
1,343.00
160.00
11.91%
Interest
121.00
675.00
-554.00
-82.07%
Exceptional Items
-71.00
-3,675.00
3,604.00
98.07%
Gross Profit (PBDT)
2,961.00
6,937.00
-3,976.00
-57.32%
Depreciation
910.00
334.00
576.00
172.46%
Profit Before Tax
401.00
-3,341.00
3,742.00
112.00%
Tax
77.00
378.00
-301.00
-79.63%
Provisions and contingencies
0
0
0.00
Profit After Tax
319.00
-3,757.00
4,076.00
108.49%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
319.00
-3,757.00
4,076.00
108.49%
Share in Profit of Associates
0
0
0.00
Minority Interest
5.00
7.00
-2.00
-28.57%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
324.00
-3,750.00
4,074.00
108.64%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
28,592.00
25,947.00
2,645.00
10.19%
Earnings per share (EPS)
0.73
-3.82
4.55
119.11%
Diluted Earnings per share
0.73
-3.82
4.55
119.11%
Operating Profit Margin (Excl OI)
14.88%
14.88%
0.00
0.00%
Gross Profit Margin
24.98%
-26.29%
0.00
51.27%
PAT Margin
6.08%
-32.85%
0.00
38.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 524.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -1.30% vs 1.20% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -3.12% vs 3.69% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 32.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -63.92% vs 37.10% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -51.57% vs 13.78% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 169.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.89% vs 9.26% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 7.78% vs 17.35% in Dec 2024

Quarterly - Interest
Interest 12.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -3.97% vs 59.49% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 59.21% vs 94.87% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.88%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024